Biotech: 2014's favored child

Now watching

Next video starts in : 7 Play

Biotech: 2014's favored child

Biotech: 2014's favored child
Replay video
Up next

Cramer: WWAV & MNST can still be bought

Unlock your personal NFL Now stream by signing in to NFL.com

Biotech: 2014's favored child

by CNBC Videos 3:25 mins

Mark Schoenebaum, ISI Group analyst, breaks down the red hot biotech sector and explains why Gilead Sciences is his best play.

View Comments (0)